Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Acta Otorrinolaringologica Espanola|April 17, 2012
Functional and oncological results of non-surgical vs surgical treatment in squamous cell carcinomas of the oropharynxJuan Pablo Díaz-Molina, Juan Pablo Rodrigo, César Alvarez-Marcos, et al.
Acta Otorrinolaringologica Espanola|December 7, 2025
Oncological and functional outcomes of nasopharyngeal carcinoma treatment in a non-endemic areaFernando López, Luis López, Patricia García-Cabo, et al.
BMC Cancer|May 21, 2013
Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)Pilar Blay, Iñigo Santamaría, Ana S Pitiot, et al.
BMC Cancer|February 23, 2017
Identification of somatic and germ-line DICER1 mutations in pleuropulmonary blastoma, cystic nephroma and rhabdomyosarcoma tumors within a DICER1 syndrome pedigreeLorena Fernández-Martínez, José Antonio Villegas, Íñigo Santamaría, et al.
Oncology|July 12, 2016
Analysis of Lynch Syndrome Mismatch Repair Genes in Women with Endometrial CancerIzaskun Rubio, Eduardo Ibáñez-Feijoo, Leire Andrés, et al.
Cancers|December 11, 2025
Matched-Pair Analysis of Survival in the Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Radiotherapy or Concurrent Chemoradiotherapy Versus Surgical-Based TreatmentPatricia García-Cabo, Daniel Pedregal-Mallo, Pilar Blay, et al.
Cancers|April 30, 2021
Matched-Pair Analysis of Survival in the Patients with Advanced Laryngeal and Hypopharyngeal Squamous Cell Carcinoma Treated with Induction Chemotherapy Plus Chemo-Radiation or Total LaryngectomyPatricia García-Cabo, Fernando López, Mario Sánchez-Canteli, et al.
BMC Cancer|May 18, 2011
Germ-line mutations in epidermal growth factor receptor (EGFR) are rare but may contribute to oncogenesis: a novel germ-line mutation in EGFR detected in a patient with lung adenocarcinomaIrene Centeno, Pilar Blay, Iñigo Santamaría, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2011
Pegylated liposomal doxorubicin and gemcitabine in a fixed dose rate infusion for the treatment of patients with poor prognosis of recurrent ovarian cancer: a phase Ib studyGuillermo Crespo, Marta Sierra, Raquel Losa, et al.
Investigational New Drugs|October 31, 2003
Activity of weekly irinotecan (CPT-11) in patients with advanced non-small cell lung cancer pretreated with platinum and taxanesRosa Sánchez, Emilio Esteban, Isabel Palacio, et al.
Pageof 2